$1.51
0.074.86%
Ult. Agg.: Nov 17, 10:11 AM
Quantum BioPharma (QNTM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.06 | $-0.63 | 90.5 % |
| Q2 | Aug 13, 2026 | $-0.47 | $-0.51 | 7.84 % |
| Q1 | May 6, 2026 | $-3.06 | $-0.56 | -446.4 % |
| Q4 | Mar 26, 2026 | $-0.71 | $-0.93 | 23.7 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q1 | May 6, 2026 | $0 | $1.50M | -100.0 % |
| Q4 | Mar 26, 2026 | $0 | $1.16M | -100.0 % |
| Q3 | Nov 7, 2025 | $0 | $1.90M | -100.0 % |
| Q2 | Aug 7, 2025 | $0 | $2.89M | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.63 | $-0.51 | $-0.56 | $-0.93 |
| Actual | $-0.06 | $-0.47 | $-3.06 | $-0.71 |
| Surprise | +90.5% | +7.84% | -446.4% | +23.7% |
| Revenue | ||||
| Estimate | — | — | $1.5M | $1.2M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | -100.0% | -100.0% |
| Metric | Q4 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-1.05 |
| Revenue | |
| Consensus | — |
